BR0013160A - Processo de indução de apoptose, processo de extermìnio de células, processo de tratamento de câncer cervical homodìmero, heterodìmero, vetor e sequência de nucleotìdeo - Google Patents

Processo de indução de apoptose, processo de extermìnio de células, processo de tratamento de câncer cervical homodìmero, heterodìmero, vetor e sequência de nucleotìdeo

Info

Publication number
BR0013160A
BR0013160A BR0013160-1A BR0013160A BR0013160A BR 0013160 A BR0013160 A BR 0013160A BR 0013160 A BR0013160 A BR 0013160A BR 0013160 A BR0013160 A BR 0013160A
Authority
BR
Brazil
Prior art keywords
vector
cervical cancer
cancer treatment
homodimeric
heterodimeric
Prior art date
Application number
BR0013160-1A
Other languages
English (en)
Inventor
Kevin Leon Gaston
Peter Lesley Stern
Anthony Russel Clarke
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of BR0013160A publication Critical patent/BR0013160A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"PROCESSO DE INDUçãO DE APOPTOSE, PROCESSO DE EXTERMìNIO DE CéLULAS, PROCESSO DE TRATAMENTO DE CâNCER CERVICAL, HOMODìMERO, HETERODìMERO, VETOR E SEQuêNCIA DE NUCLEOTìDEO". A invenção refere-se a processos para induzir a morte celular.
BR0013160-1A 1999-07-13 2000-07-13 Processo de indução de apoptose, processo de extermìnio de células, processo de tratamento de câncer cervical homodìmero, heterodìmero, vetor e sequência de nucleotìdeo BR0013160A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9916363.6A GB9916363D0 (en) 1999-07-13 1999-07-13 Methods of suppressing cell growth
PCT/GB2000/002693 WO2001003717A2 (en) 1999-07-13 2000-07-13 Methods of inducing cell death

Publications (1)

Publication Number Publication Date
BR0013160A true BR0013160A (pt) 2002-07-30

Family

ID=10857133

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013160-1A BR0013160A (pt) 1999-07-13 2000-07-13 Processo de indução de apoptose, processo de extermìnio de células, processo de tratamento de câncer cervical homodìmero, heterodìmero, vetor e sequência de nucleotìdeo

Country Status (15)

Country Link
US (1) US20030130184A1 (pt)
EP (1) EP1196595A2 (pt)
JP (1) JP2003504342A (pt)
KR (1) KR20020025195A (pt)
CN (1) CN1372598A (pt)
AU (1) AU6168800A (pt)
BR (1) BR0013160A (pt)
CA (1) CA2379010A1 (pt)
GB (1) GB9916363D0 (pt)
HU (1) HUP0202163A2 (pt)
IL (1) IL147594A0 (pt)
NZ (1) NZ516773A (pt)
PL (1) PL353771A1 (pt)
WO (1) WO2001003717A2 (pt)
ZA (1) ZA200200339B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117905D0 (en) * 2001-07-23 2001-09-12 Univ Bristol An inducer of apoptosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4123760C2 (de) * 1991-07-18 2000-01-20 Dade Behring Marburg Gmbh Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
JPH09500540A (ja) * 1993-07-30 1997-01-21 メデヴァ ホールディングス ビー．ヴイ． ワクチン組成物
WO1998001148A1 (en) * 1996-07-09 1998-01-15 President And Fellows Of Harvard College Use of papillomavirus e2 protein in treating papillomavirus-infected cells and compositions containing the protein
FR2758725B1 (fr) * 1997-01-29 1999-04-02 Pasteur Institut Composition comprenant une proteine e2 de papillomavirus ou une sequence de nucleotides codant pour une proteine e2 de papillomavirus

Also Published As

Publication number Publication date
HUP0202163A2 (en) 2002-10-28
ZA200200339B (en) 2002-12-24
JP2003504342A (ja) 2003-02-04
PL353771A1 (en) 2003-12-01
IL147594A0 (en) 2002-08-14
US20030130184A1 (en) 2003-07-10
WO2001003717A3 (en) 2001-11-15
EP1196595A2 (en) 2002-04-17
NZ516773A (en) 2004-01-30
CA2379010A1 (en) 2001-01-18
GB9916363D0 (en) 1999-09-15
KR20020025195A (ko) 2002-04-03
CN1372598A (zh) 2002-10-02
AU6168800A (en) 2001-01-30
WO2001003717A2 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
BR0110610A (pt) Anticorpos isolados, imunoconjugados, cadeias de polipeptìdeos, ácido nucléico isolado, vetor, célula hospedeira, processo de produção de anticorpo ou cadeia de polipeptìdeos, método de tratamento de disfunções em mamìferos, método de indução da apoptose de uma célula cancerosa, método para matar uma célula b, método para matar uma célula que expresse um receptor de erbb e usos dos anticorpos isolados
IL173888A0 (en) Novel tricyclic nucleosides or nucleotides as therapeutic agents
FR12C0004I1 (pt)
NO20001598D0 (no) Apolipoprotein A-1-agonister og deres anvendelse for Õ behandle dyslipidemiske forstyrrelser
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
BR9911781B1 (pt) iluminador para terapia fotodinámica.
ATE279407T1 (de) Fsh mimetika zur behandlung von infertilität
EP1381280A4 (en) VIRAL VECTORS AND USE THEREOF IN THERAPEUTIC METHODS
EP1117672A4 (en) ANTISENSE MODULATION OF THE SURVIVIN EXPRESSION
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
DE69930330D1 (de) Durchlaufwärmebehandlungsofen
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE60213221D1 (de) Neuartige polynukleotide und polypeptide des ifnalpha-21 gens
DE69821793D1 (de) Neuronale verwendungen des bmp-11
IL151692A0 (en) Polyamine analogues as cytotoxic agents
WO2003105755A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION
WO2003104397A3 (en) ANTISENSE MODULATION OF PROTEIN KINASE GR 6 EXPRESSION
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
DE60231986D1 (de) Oligonukleotid-zusammansetzungen und deren verwendung zur induzierung von apoptose
BR0013160A (pt) Processo de indução de apoptose, processo de extermìnio de células, processo de tratamento de câncer cervical homodìmero, heterodìmero, vetor e sequência de nucleotìdeo
MXPA02001204A (es) Compuestos calciliticos.
DE69821919D1 (de) Fischprotein, dessen gen, reagenzien zur induktion von apoptose, und antikrebsmittel
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.